• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Anaveon

News headline image
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer
May 19, 2026
From Anaveon
Via GlobeNewswire
News headline image
Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors
May 13, 2026
From Anaveon
Via GlobeNewswire
News headline image
Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
May 11, 2026
From Anaveon
Via GlobeNewswire
News headline image
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
March 23, 2026
From Anaveon
Via GlobeNewswire
News headline image
Anaveon announces presentation of new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting
October 30, 2024
From Anaveon
Via GlobeNewswire
News headline image
Anaveon appoints Dieter Weinand as Chair of its Board of Directors
July 30, 2024
From Anaveon
Via GlobeNewswire
News headline image
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
May 29, 2024
From Anaveon
Via GlobeNewswire
News headline image
Anaveon announces presentation of a novel development compound at the 2023 American Association for Cancer Research Annual Meeting
March 23, 2023
From Anaveon
Via GlobeNewswire
News headline image
Anaveon announces first patient dosed with ANV419 in a Phase I/II Study of ANV419 in patients with multiple myeloma
March 16, 2023
From Anaveon
Via GlobeNewswire
News headline image
Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy or in combination with check point inhibitors in patients with advanced melanoma
February 02, 2023
From Anaveon
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap